4
Changes in Ownership
RHYTHM PHARMACEUTICALS, INC. Filed Acc 0001104659-26-077305
Director sold 37,000 shares at $100.32 ($3,711,896)
- Director acquired 37,000 shares (option exercise)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| TETRAULT LYNN A. Director | 2026-06-22 | Option exercise 10b5-1 | +37,000 | $28.27 | $1,045,990 | 44,000 | D |
| TETRAULT LYNN A. Director | 2026-06-22 | Sale 10b5-1 | −37,000 | $100.32 | $3,711,896 | 7,000 | D |
| Derivatives | |||||||
| TETRAULT LYNN A. Director | 2026-06-22 | Option exercise · Stock Option (right to buy) 10b5-1 | −37,000 | 0 | D | ||
| Open-market sales · 37,000 sh · avg $100.32 · $3,711,896 | |||||||
Loading xslF345X06/tm2618690-1_4seq1.xml…